-
Calcium and vitamin D supplements are widely prescribed to women undergoing treatment for breast cancer to prevent and manage osteoporosis. Why?
-
Risks and Benefits of an Extended 10-year Tamoxifen Regimen for Breast Cancer; Is There More Pro than Con in Probiotics in Critically Ill Adults?; Are OSA Outcomes Better in the Hands of Sleep Specialists than Primary Care Clinicians?;Inhaled Steroids Increase Risk of TB in COPD Patients; The ASH Position Paper on Orthostatic Hypotension
-
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer.
-
-
In one of its final acts, the lame-duck 112th Congress did something unprecedented over its two-year term: It expanded access to publicly financed abortion, ever so slightly.
-
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011.
-
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test.
-
-
Sterilization continues to be a leading contraceptive choice for women in the United States; between 2006 and 2008, 10.3 million women looked to the method for birth control.
-
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.
